Business Context and Reporting Period
This Form 6-K filing by Mega Matrix Inc. covers the month of October 2025. The report discloses significant changes to the Company's Board of Directors, specifically the resignation of a director and the immediate appointment of a replacement.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignation: Ms. Siyuan Zhu resigned from all Board positions, including committee memberships, effective October 14, 2025. The resignation is for personal reasons and is not related to any disagreement regarding operations, policies, or accounting practices.
- Appointment: Dr. Yunhao Chen was appointed as an independent director, member of the Compensation and Audit Committees, and Chairperson of the Audit Committee, effective October 14, 2025.
- Compensation: Dr. Chen's compensation package includes an annual cash fee of $36,000 and a grant of 24,000 restricted share units vesting quarterly starting December 31, 2025.
Outlook, Risks, and Management Commentary
Management confirms that Dr. Chen brings extensive experience in U.S. GAAP, SEC reporting, and financial management, having previously served as CFO for Massimo Group and Dogness International Corporation. The filing states there are no family relationships between Dr. Chen and other directors or officers, and no undisclosed material interests in transactions. No specific risks, contingencies, or unusual items regarding financial operations are disclosed in this text.
Key Facts for Investor Verification
- Verify the effective date of Dr. Yunhao Chen's appointment and the specific vesting schedule of the 24,000 restricted share units.
- Confirm the absence of any undisclosed disagreements or issues related to Ms. Zhu's departure by reviewing the full Board minutes if available.
- Review the full text of the Independent Director Agreement (Exhibit 10.2) and Indemnification Agreement (Exhibit 10.1) for complete terms.
- Check subsequent filings for any impact on the Audit Committee's quorum or operations following the leadership change.